Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of respiratory muscle function in ALS patients with heavy metal poisoning
2010-020010-28Phase 4Terminated
- Sponsor
- University of Parma
- Start
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of edetate calcium disodium in amyotrophic lateral sclerosis (ALS), sponsored by University of Parma. Primary endpoints: Evaluation of heavy metal poisoning in ALS patients and Role of heavy metal poisoning in ALS progression. Started Jul 2010; status: terminated.
02
Drugs
edetate calcium disodium
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on 2010-020010-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020010-28.